Travere Therapeutics, Inc. (TVTX) has a consensus analyst rating of Buy, based on 18 analysts covering the stock. Of those, 15 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for TVTX is $49.00, representing a +16.3% upside from the current price of $42.13. Price targets range from a low of $49.00 to a high of $49.00.
